KRT9 and epidermolytic palmoplantar keratoderma, 1: Correction of a dominant-negative mutation within KRT9, causing epidermolytic palmoplantar keratoderma (EPPK), was achieved using a mutation-specific CRISPR/Cas9-based strategy.